search
Back to results

The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device

Primary Purpose

Dyspareunia

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mollie device
Sponsored by
JSP Innovations
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dyspareunia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Females 18 years of age and older with a diagnosis of collision dyspareunia -

Exclusion Criteria:

-

Sites / Locations

  • Vero ClinicsRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Treatment

Sham

Arm Description

Actual treatment device

Sham/placebo device

Outcomes

Primary Outcome Measures

Dyspareunia Alleviation
The Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v.4.0, Change from Baseline in Pain Scores on the Visual Analog Scale at 13 Weeks

Secondary Outcome Measures

Full Information

First Posted
June 24, 2022
Last Updated
June 30, 2022
Sponsor
JSP Innovations
search

1. Study Identification

Unique Protocol Identification Number
NCT05445115
Brief Title
The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device
Official Title
DAT: Dyspareunia Alleviation Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 14, 2021 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
April 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
JSP Innovations

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Study to evaluate the use of a medical device in relieving collision dyspareunia

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspareunia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Treatment arm and sham arm
Masking
Participant
Masking Description
Subjects are blinded as to which arm they are participating in
Allocation
Randomized
Enrollment
111 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
Actual treatment device
Arm Title
Sham
Arm Type
Sham Comparator
Arm Description
Sham/placebo device
Intervention Type
Device
Intervention Name(s)
Mollie device
Other Intervention Name(s)
Sham
Intervention Description
medical device
Primary Outcome Measure Information:
Title
Dyspareunia Alleviation
Description
The Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v.4.0, Change from Baseline in Pain Scores on the Visual Analog Scale at 13 Weeks
Time Frame
12 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Females 18 years of age and older with a diagnosis of collision dyspareunia - Exclusion Criteria: -
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leigh Ann Grossman
Phone
217-615-1144
Email
leighann176@yahoo.com
Facility Information:
Facility Name
Vero Clinics
City
Decatur
State/Province
Illinois
ZIP/Postal Code
62526
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leigh Ann Grossman
Phone
217-615-1144
Email
leighann176@yahoo.com

12. IPD Sharing Statement

Learn more about this trial

The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device

We'll reach out to this number within 24 hrs